Re-amputation of the hand at the transmetacarpal level — a secondary surgical revision following a prior transmetacarpal amputation.
Verified May 8, 2026 · 6 sources ↓
- Medicare
- $782.25
- Total RVUs
- 23.42
- Global, days
- 90
- Region
- Hand
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 6 cited references ↓
- Operative note must explicitly state this is a re-amputation, not secondary wound closure or scar revision (25929 describes those separately)
- Document the level of re-amputation and the specific transmetacarpal ray(s) involved
- State the clinical indication — complication, residual limb breakdown, prosthetic fitting failure — with supporting pre-op findings
- Identify whether this re-amputation is staged/planned (modifier 58) or unplanned return for a related complication (modifier 78)
- If modifier 22 is appended, the operative note must quantify the additional work and time above the typical procedure
- Record laterality (right or left hand) to support LT/RT modifier use
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 6 cited references ↓
CPT 25931 describes a re-amputation performed at the transmetacarpal level, following a previous transmetacarpal amputation (25927). This is a distinct secondary procedure — not routine post-op wound care — indicated when the residual limb requires surgical revision to address complications, refine the stump, or optimize prosthetic fitting. It sits at the end of the 25900–25931 forearm and wrist amputation code family, specifically as the re-amputation following 25927 (transmetacarpal amputation).
The 90-day global period means all routine post-op care through day 90 is bundled. Any unrelated E/M or procedure billed within that window requires modifier 24 or 79, respectively. Because this is already a secondary procedure by definition, document clearly that it is a planned or staged re-amputation — not just wound management — to distinguish it from services that would be bundled under the original amputation's global period.
Site of service matters here. Medicare assigns 25931 a J1 status indicator in the HOPD setting, and it carries an ASC G2 status indicator, meaning ASC payment is based on the OPPS relative rate and is subject to the multiple-procedure discount. Confirm facility status before submitting, as HOPD and ASC payments differ materially (see the Site of Service comparison table).
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 7.84 |
| Practice expense RVU | 13.91 |
| Malpractice RVU | 1.67 |
| Total RVU | 23.42 |
| Medicare national rate | $782.25 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $782.25 |
HOPD (APC 5113) Hospital outpatient department | $3,342.87 |
ASC (PI G2) Ambulatory surgical center (freestanding) | $1,644.87 |
Common denial reasons
The recurring reasons claims for CPT 25931 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Procedure billed during the global period of the original amputation without an appropriate modifier (58, 78, or 79) to indicate its relationship to the prior surgery
- 25931 confused with 25929 (secondary closure or scar revision) — payers deny when the operative note describes wound revision rather than true re-amputation
- Missing or insufficient documentation of medical necessity for the re-amputation, particularly when the indication is prosthetic optimization rather than acute complication
- Site-of-service mismatch — claim submitted for ASC but documentation or facility type does not support outpatient setting eligibility
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01How is 25931 different from 25929?
02What modifier applies if 25931 is performed during the global period of the original amputation?
03Can 25931 be billed bilaterally?
04Is 25931 payable in an ASC?
05When is modifier 22 justified for 25931?
06Does the 90-day global period for 25931 start fresh after the re-amputation?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02emedny.orghttps://www.emedny.org/providermanuals/physician/pdfs/physician%20procedure%20codes%20sect5.pdf
- 03cms.govhttps://www.cms.gov/files/document/02-chapter2-ncci-medicare-policy-manual-2025finalcleanpdf.pdf
- 04axogeninc.comhttps://www.axogeninc.com/wp-content/uploads/2025/04/2025-Neurectomy-Post-Amputation-Coding-Guide.pdf
- 05mdclarity.comhttps://www.mdclarity.com/cpt-code/25931
- 06aapc.comhttps://www.aapc.com/codes/cpt-codes-range/25900-25931/
Mira AI Scribe
Mira's AI scribe captures the re-amputation level, specific transmetacarpal ray(s) resected, clinical indication, and whether the procedure is staged or an unplanned return — pulling these directly from surgeon dictation. That prevents the most common denial: a note that reads like wound revision (25929) when the procedure is a true re-amputation (25931), or a missing global-period modifier that triggers automatic bundling with the original amputation.
See how Mira captures CPT 25931 documentation